Diagnosing and treating catatonia: An update

Current Psychiatry Reviews

Volumn 9, Issue 2, 2013, Pages 130-135

  Gazdag, Gábor ^a,b   Sienaert, Pascal ^c  

^a Szent Istvan and Szent Laszlo Hospitals   (Hungary)

^b SEMMELWEIS UNIVERSITY   (Hungary)

^c UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Benzodiazepine; Catatonia; Electroconvulsive therapy; Rating scale

Indexed keywords

BENZODIAZEPINE DERIVATIVE; CLOZAPINE; LORAZEPAM; OLANZAPINE;

ARTICLE; BIPOLAR DISORDER; CATATONIA; CATATONIC SCHIZOPHRENIA; CLINICAL EXAMINATION; DEPRESSION; ELECTROCONVULSIVE THERAPY; HUMAN; LABORATORY TEST; MOOD DISORDER; PRIORITY JOURNAL; RATING SCALE; SCHIZOPHRENIA;

EID: 84878638686     PISSN: 15734005     EISSN: 18756441     Source Type: Journal    
DOI: 10.2174/1573400511309020007     Document Type: Article

References (65)

1. Kahlbaum KL. (Levi Y, Pridon T, trans.) Catatonia. Baltimore, Md: John Hopkins University Press; 1973.
2. van der Heijden FM, Tuinier S, Arts NJ, Hoogendoorn ML, Kahn RS, Verhoeven WM. Catatonia: disappeared or under-diagnosed? Psychopathology. 2005; 38: 3-8.
3. Daniels J. Catatonia: clinical aspects and neurobiological correlates. J Neuropsychiatry Clin Neurosci. 2009; 21: 371-80.
4. Fink M, Shorter E, Taylor MA. Catatonia is not schizophrenia: Kraepelin's error and the need to recognize catatonia as an independent syndrome in medical nomenclature. Schizophr Bull. 2010; 36: 314-20.
5. Sienaert P, Rooseleer J, De Fruyt J. Measuring catatonia: a systematic review of rating scales. J Affect Disord. 2011; 135: 1-9.
6. Fink M. Catatonia from its creation to DSM-V: Considerations for ICD. Indian J Psychiatry. 2011; 53: 214-7.
7. Fink M, Taylor MA. Catatonia. A clinicians guide to diagnosis and treatment. 1st ed. Cambridge: Cambridge University Press; 2003.
8. Taylor MA, Fink M. Catatonia in psychiatric classification: a home of its own. Am J Psychiatry 2003; 160: 1233-41.
9. Dhossche DM, Stoppelbein L, Rout UK. Etiopathogenesis of catatonia: generalizations and working hypotheses. J ECT 2010; 26: 253-8.
10. Francis A, Fink M, Appiani F, et al. Catatonia in Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. J ECT, 2010; 26: 246-247.
11. Kirkhart R, Ahuja N, Lee JW, et al. The detection and measurement of catatonia. Psychiatry (Edgmont) 2007; 4, 52-56.
12. American Psychiatric Association. DSM-IV: Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Press Inc.; 1994.
13. World Health Organization. The ICD-10 Classification of Mental and Behavioural Disorders. Geneva, Switzerland: World Health Organization; 1992.
14. Ungvari GS, Caroff SN, Gerevich J. The catatonia conundrum: Evidence of psychomotor phenomena as a symptom dimension in psychotic disorders. Schizophrenia Bulletin 2010; 36: 231-238.
15. Nothoff G. What catatonia can tell us about "top-down modulation": a neuropsychiatric hypothesis. Behav Brain Sci. 2002; 25: 555-577.
16. Gelenberg AJ, Mandel MR. Catatonic reactions to high potency neuroleptic drugs. Arch. Gen. Psychiatry 1977; 34: 947-950.
17. Fricchione GL, Cassem NH, Hooberman D et al. Intravenous lorazepam in neuroleptic-induced catatonia. J. Clin. Psychopharmacol. 1983; 3: 338-342.
18. Cremona-Barbaro A. Neuroleptic-induced catatonic symptoms. Br J Psychiatry 1983; 42: 98-99.
19. Carroll BT, Lee JWY, Appiani F, Thomas C. The pharmacotherapy of catatonia. Primary Psychiatry 2010; 17: 41-47.
20. Hawkins JM, Archer KJ, Strakowski SM, Keck PE. Somatic treatment of catatonia. Int J Psychiatry Med. 1995; 25: 345-69.
21. Rosebush PI, Hildebrand AM, Furlong BG, Mazurek MF. Catatonic syndrome in a general psychiatric inpatient population: frequency, clinical presentation, and response to lorazepam. J Clin Psychiatry 1990; 51: 357-62.
22. Ungvari GS, Leung CM, Wong MK, Lau J. Benzodiazepines in the treatment of catatonic syndrome. Acta Psychiatr Scand 1994; 89: 285-8.
23. Bush G, Fink M, Petrides G, Dowling F, Francis A. Catatonia II. Treatment with lorazepam and electroconvulsive therapy. Acta Psychiatr Scand 1996; 93: 137-43.
24. Fink M. Catatonia: syndrome or schizophrenia subtype? Recognition and treatment. J Neural Transm 2001; 108: 637-44.
25. Hatta K, Miyakawa K, Ota T, et al. Maximal response to electroconvulsive therapy for the treatment of catatonic symptoms. J ECT 2007; 23: 233-5.
26. Rosebush PI, Mazurek MF. Catatonia: re-awakening to a forgotten disorder. Mov Disord 1999; 14: 395-7.
27. Ungvari GS, Chiu HFK, Chow LY, et al. Lorazepam for chronic catatonia: a randomized, double-blind, placebo-controlled crossover study. Psychopharmacology 1999; 142: 393-8 (Berl.).
28. Beckmann H, Fritze J, Franzek E. The influence of neuroleptics on specific syndromes and symptoms in schizophrenics with unfavourable long-term course. A 5-year follow-up study of 50 chronic schizophrenics. Neuropsychobiology. 1992; 26: 50-58.
29. Naber D, Holzbach R, Perro C, Hippius H. Clinical management of clozapine patients in relation to efficacy and side-effects. Br J Psychiatry 1992; 160: 54-9.
30. Martényi F, Metcalfe S, Schausberger B, Dossenbach MRK. An efficacy analysis of olanzapine treatment data in schizophrenia patients with catatonic signs and symptoms. J Clin Psychiatry 2001; 62: 25-7.
31. van den Eede F, van Hecke J, van Dalfsen A, van den Bossche B, Cosyns P, Sabbe BGC. The use of atypical antipsychotics in the treatment of catatonia. European Psychiatry 2005; 20: 422-429.
32. Lauterbach EC. Catatonia-like events after valproic acid with risperidone and sertraline. Neuropsychiatry Neuropsychol Behav Neurol 1998; 11: 157-63.
33. Bahro M, Kämpf C, Strnad J. Catatonia under medication with risperidone in a 61-year-old patient. Acta Psychiatr Scand 1999; 99: 223-6.
34. Girish K, Gill NS. Electroconvulsive therapy in lorazepam non-responsive catatonia. Indian Journal of Psychiatry 2003; 45: 21-5.
35. Fink M. Is catatonia a primary indication for ECT? J ECT 1990; 6: 1-4.
36. Waller K, Borik A, Choi C. Breast cancer, bipolar disorder, catatonia, and life-preserving electroconvulsive therapy. Psychosomatics 2000; 41: 442-45.
37. Boyarsky BK, Fuller M, Early T. Malignant catatonia-induced respiratory failure with response to ECT. J ECT 1999; 15: 232-236.
38. Smith M, LeBegue B. Lorazepam in the treatment of catatonia. (letter) Am J Psychiatry 1991; 148: 1265.
39. Malur C, Francis A. Emergence of catatonia during ECT. J ECT 2001; 17: 201-204.
40. Petrides G, Divadeenam K, Bush G, Francis A. Synergism of lorazepam and electroconvulsive therapy in the treatment of catatonia. Biol Psychiatry 1997; 42: 375-381.
41. Yeung PP, Milstein RM, Daniels DC, Bowers MB Jr. ECT for lorazepam-refractory catatonia. Convuls Ther 1996; 12: 31-5.
42. Rohland BM, Carroll BT, Jacoby RG. ECT in the treatment of the catatonic syndrome. J Affective Disorders 1993; 29: 255-261.
43. Pataki J, Zervas IM, Jandorf L. Catatonia in a University in-patient service (1985-1990). Convulsive Ther 1992; 8: 163-173.
44. Dodwell D, Goldberg D. A study of factors associated with response to electroconvulsive therapy in patients with schizophrenic symptoms. Br J Psychiatry 1989; 154: 635-9.
45. Caroff SN, Mann SC, Campbell EC, Sullivan KA. Epidemiology. In Catatonia: From psychopathology to neurobiology (eds. Caroff, S. N., Mann, S. C., Francis, A., and Fricchione, G. L.). Washington, DC: American Psychiatric Press, 2004, pp. 15-31.
46. Fink M. Convulsive therapy: theory and practice. New York, Raven Press, 1979.
47. Habson B. Prognostic factors in electricconvulsive therapy. J Neurol Neurosurg Psychiatry 1953; 16: 275-81.
48. Mendels J. The prediction of response to electroconvulsive therapy. Am J Psychiatry 1967; 124: 153-9.
49. Weckowicz TE, Yonge KA, Crapley AJ, Muir W. Objective therapy predictors in depression: A multivariate approach. J Clin Psychopathology. 1971; 27: 4-29.
50. Maletzky BM. The first-line use of electroconvulsive therapy in major affective disorders. J ECT 2004; 20: 112-7.
51. Escobar R, Rios A, Montoya ID, et al. Clinical and cerebral blood flow changes in catatonic patients treated with ECT. J Psychosom Res 2000; 49: 423-9.
52. American Psychiatric Association (APA). The practice of ECT: Recommendations for treatment, training and privileging. Washington, DC: American Psychiatric Press, 2001.
53. Rudorfer MV, Henry ME, Sackeim HA. Electroconvulsive therapy in Psychiatry, Second Edition, Tasman A., Kay J., Leiberman J. (Editors), John Wiley & Sons, New York, 2003.
54. Mukherjee S, Sackeim HA, Schnur DB. Electroconvulsive therapy of acute mania episodes: a review of 50 years experience. Am J Psychiatry 1994; 151: 169-76.
55. Morrison JR. Catatonia: Prediction of outcome. Compr Psychiatry 1974; 15: 317-24.
56. Abrams R, Taylor MA. Catatonia: A prospective clinical study. Arch Gen Psychiatry 1976; 33: 579-81.
57. Meduna L. Die Konvulsionstherapie der Schizophrenie. Carl Marhold, Halle, 1937.
58. Wells DA. Electroconvulsive treatment for schizophrenia. A ten-year survey in a university hospital psychiatric department. Compr Psychiatry 1973; 14: 291-8.
59. Finkbeiner T. EKT-behandlung katatoner psychosen: Indikation und praktische durchfuhrung. In Differnzierung katatoner und neuroleptika-induzierter Bewegungsstorungen (ed. Braunig, P.). Stuttgart-New York: Thieme, 1995, pp. 98-104.
60. Mann SC, Caroff SN, Bleier HR, et al. Lethal catatonia. Am J Psychiatry 1986; 143: 1374-81.
61. Mann SC, Caroff SN, Fricchione G, et al. Malignant catatonia In Catatonia: From psychopathology to neurobiology (eds. Caroff SN, Mann SC, Francis A, and Fricchione G). Washington, DC: American Psychiatric Publishing, 2004, pp. 105-19.
62. Arnold OH, Stepan H. Untersuchungen zur frage der akuten todlicken katatonie. Wien Z Nervenheilkd Grenzgeb 1952; 4: 235-58.
63. Sedivec V. Psychoses endangering life (in Czech). Cesk Psychiatr 1981; 77: 38-41.
64. Mann SC, Caroff SN, Keck PE Jr., et al. The neuroleptic malignant syndrome and related conditions, 2nd edn. Washington, DC: American Psychiatric Publishing, 2003.
65. Philbrick K, Rummans TA. Malignant catatonia. J Neuropsychiatry Clin Neurosci 1994; 6: 1-13.